BET inhibitors enhance embryonic and fetal globin expression in erythroleukemia cell lines by John Z. Cao, Kristina Bigelow, Amittha Wickrema, and Lucy A. Godley Received: March 16, 2021. Accepted: August 20, 2021. Citation: John Z. Cao, Kristina Bigelow, Amittha Wickrema, and Lucy A. Godley. BET inhibitors enhance embryonic and fetal globin expression in erythroleukemia cell lines. Haematologica. 2021 Aug 26. doi: 10.3324/haematol.2021.278791. [Epub ahead of print] Publisher's Disclaimer. E-publishing ahead of print is increasingly important for the rapid dissemination of science. Haematologica is, therefore, E-publishing PDF files of an early version of manuscripts that have completed a regular peer review and have been accepted for publication. E-publishing of this PDF file has been approved by the authors. After having E-published Ahead of Print, manuscripts will then undergo technical and English editing, typesetting, proof correction and be presented for the authors' final approval; the final version of the manuscript will then appear in a regular issue of the journal. All legal disclaimers that apply to the journal also pertain to this production process. BET inhibitors enhance embryonic and fetal globin expression in erythroleukemia cell lines John Z. Cao1, Kristina Bigelow2, Amittha Wickrema1,2, and Lucy A. Godley1,2* 1 Committee on Cancer Biology, Biological Sciences Division, The University of Chicago, Chicago IL 2 Section of Hematology/Oncology, Department of Medicine, The University of Chicago, Chicago IL *Corresponding author Contact information: 5841 S. Maryland Ave. MC 2115 Chicago, IL 60637 Phone: 773-702-4140 FAX: 773-702-9268 Email:
[email protected] Author Contribution J.Z.C.